Health Care
Commentary
Obamacare insurers collect billions in taxpayer subsidies — just to deny claims
Democrats spent the last four years trying to expand Obamacare enrollment, largely by ramping up federal premium subsidies. However, the health coverage available through the exchanges often doesn’t do much good, as too many Obamacare enrollees discover when a medical bill comes due. Read the op-ed here.
Commentary
The World’s Medicine Chest
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special live ...
Drug Innovation
Why Failure-to-Market Claims Are Preempted Under Federal Law
A California appellate court invented out of whole cloth a new and troubling theory of tort liability. Specifically, the court held that drug companies have a duty to develop and bring to market drugs that are supposedly safer and more effective than another, FDA-approved drug the company sells already. The ...
Commentary
Unaffordable Medicaid Means We Should Forget It
U.S. House Republicans recently released a list of proposals for slashing federal spending by as much as $5.7 trillion. A significant portion of the proposed savings — a whopping $2.3 trillion — would come from Medicaid. Progressives are decrying the GOP document as a heartless assault on an essential safety-net ...
Book
Read the new book from Sally Pipes “The World’s Medicine Chest”
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special ...
Commentary
Insulin prices are falling due to market forces — no price caps required
California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
Commentary
The CFPB’s New Medical Debt Rule Will Do More Harm Than Good
The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Commentary
Patients Pay Dearly for Biden’s Pricing Mess
On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
Commentary
RFK Jr.’s Confirmation Hearings Can’t Leave This Question Unanswered
On this Wednesday and Thursday, two powerful Senate committees will hold confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the Department of Health and Human Services. RFK Jr. is no stranger to controversy. But his most radical policy position may be one that relatively few people ...
Commentary
Republicans, don’t give up on healthcare reform
In his first week back in the White House, President Donald Trump issued several executive orders related to health policy. But lasting action on healthcare reform, from reining in wasteful or fraudulent Medicaid spending to rolling back billions in premium subsidies, can only come from Congress, which holds the power ...
Obamacare insurers collect billions in taxpayer subsidies — just to deny claims
Democrats spent the last four years trying to expand Obamacare enrollment, largely by ramping up federal premium subsidies. However, the health coverage available through the exchanges often doesn’t do much good, as too many Obamacare enrollees discover when a medical bill comes due. Read the op-ed here.
The World’s Medicine Chest
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special live ...
Why Failure-to-Market Claims Are Preempted Under Federal Law
A California appellate court invented out of whole cloth a new and troubling theory of tort liability. Specifically, the court held that drug companies have a duty to develop and bring to market drugs that are supposedly safer and more effective than another, FDA-approved drug the company sells already. The ...
Unaffordable Medicaid Means We Should Forget It
U.S. House Republicans recently released a list of proposals for slashing federal spending by as much as $5.7 trillion. A significant portion of the proposed savings — a whopping $2.3 trillion — would come from Medicaid. Progressives are decrying the GOP document as a heartless assault on an essential safety-net ...
Read the new book from Sally Pipes “The World’s Medicine Chest”
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special ...
Insulin prices are falling due to market forces — no price caps required
California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
The CFPB’s New Medical Debt Rule Will Do More Harm Than Good
The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Patients Pay Dearly for Biden’s Pricing Mess
On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
RFK Jr.’s Confirmation Hearings Can’t Leave This Question Unanswered
On this Wednesday and Thursday, two powerful Senate committees will hold confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the Department of Health and Human Services. RFK Jr. is no stranger to controversy. But his most radical policy position may be one that relatively few people ...
Republicans, don’t give up on healthcare reform
In his first week back in the White House, President Donald Trump issued several executive orders related to health policy. But lasting action on healthcare reform, from reining in wasteful or fraudulent Medicaid spending to rolling back billions in premium subsidies, can only come from Congress, which holds the power ...
